ÂÜÀòÂÒÂ×

Dr. Verheye has been a senior interventional cardiologist at the Antwerp Cardiovascular Center, Antwerp Belgium since 2000. He serves as a member of the Scientific Advisory Board of several medical device manufacturers.

He is a member of the European Association of Percutaneous Cardiovascular Interventions and a member of the Belgian Working Group on Interventional Cardiology and has been appointed as Visiting Professor at the University of Brussels. Dr. Verheye is the author of over 150 peer-reviewed journals (www.pubmed.com), ten book chapters, over 300 abstracts, and has led (as global principal investigator) and participated in numerous clinical (Phase I and II) and pre-clinical research studies in the field of innovative interventional cardiology (coronary and structural heart disease). He has presented at numerous major conferences such as TCT (Transcatheter Cardiovascular Therapeutics), EuroPCR (European Percutaneous Course on Revascularization), AsiaPCR, AHA (American Heart Association), ACC (American College of Cardiology) and ESC (European Society of Cardiology), and has directed and transmitted several coronary and structural live cases to TCT, EuroPCR, and ESC. His entrepreneurial interests led to the co-foundation of Hilbert Paradox, NV, a start-up company encompassing a unique way of capturing and correlating digital health data, applying data- and knowledge engineering, which was later on acquired by a clinical research organization. Afterward, he co-founded ainthoven, NV, a start-up company dedicated to online cardiac signal analytics by exploring the hyperspace of learning algorithms.